A positive regulatory role for suppressor of cytokine signaling 1 in IFN-γ-induced MHC class II expression in fibroblasts

Journal of Immunology

Volumn 169, Issue 9, 2002, Pages 5010-5020

  Ilangumaran, Subburaj ^a   Finan, Dina ^a   La Rose, José ^a   Raine, Jason ^a   Silverstein, Anna ^a   De Sepulveda, Paulo ^a   Rottapel, Robert ^a  

^a PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; JANUS KINASE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; STAT1 PROTEIN;

ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DEATH; EMBRYO; EMBRYO CELL; ENZYME INHIBITION; FEEDBACK SYSTEM; FIBROBLAST; GENE EXPRESSION; GENETIC TRANSDUCTION; GROWTH INHIBITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; RETROVIRUS; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; SRC HOMOLOGY DOMAIN; SUPPRESSOR CELL; WILD TYPE;

EID: 0036838691     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.169.9.5010     Document Type: Article

References (62)

1. Krebs, D. L., and D. J. Hilton. 2000. SOCS: Physiological suppressors of cytokine signaling. J. Cell Sci. 113:2813.
2. Marine, J. C., D. J. Topham, C. McKay, D. Wang, E. Parganas, D. Stravopodis, A. Yoshimura, and J. N. Ihle. 1999. SOCS1 deficiency causes a lymphocyte-dependent perinatal lethality. Cell 98:609.
3. Marine, J. C., C. McKay, D. Wang, D. J. Topham, E. Parganas, H. Nakajima, H. Pendeville, H. Yasukawa, A. Sasaki, A. Yoshimura, and J. N. Ihle. 1999. SOCS3 is essential in the regulation of fetal liver erythropoiesis. Cell 98:617.
4. Metcalf, D., C. J. Greenhalgh, E. Viney, T. A. Willson, R. Starr, N. A. Nicola, D. J. Hilton, and W. S. Alexander. 2000. Gigantism in mice lacking suppressor of cytokine signalling-2. Nature 405:1069.
5. Naka, T., T. Matsumoto, M. Narazaki, M. Fujimoto, Y. Morita, Y. Ohsawa, H. Saito, T. Nagasawa, Y. Uchiyama, and T. Kishimoto. 1998. Accelerated apoptosis of lymphocytes by augmented induction of Bax in SSI-1 (STAT-induced STAT inhibitor-1) deficient mice. Proc. Natl. Acad. Sci. USA 95:15577.
6. Mach, B., V. Steimle, E. Martinez-Soria, and W. Reith. 1996. Regulation of MHC class II genes: Lessons from a disease. Annu. Rev. Immunol. 14:301.
7. Reith, W., and B. Mach. 2001. The bare lymphocyte syndrome and the regulation of MHC expression. Annu. Rev. Immunol. 19:331.
8. Meraz, M. A., J. M. White, K. C. Sheehan, E. A. Bach, S. J. Rodig, A. S. Dighe, D. H. Kaplan, J. K. Riley, A. C. Greenlund. D. Campbell, et al. 1996. Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway. Cell 84:431.
9. Boehm, U., T. Klamp, M. Groot, and J. C. Howard. 1997. Cellular responses to interferon-γ. Annu. Rev. Immunol. 15:749.
10. Chang, C. H., S. Guerder, S. C. Hong, W. van Ewijk, and R. A. Flavell. 1996. Mice lacking the MHC class II transactivator (CIITA) show tissue-specific impairment of MHC class II expression. Immunity 4:167.
11. Chang, C. H., J. Hammer, J. E. Loh, W. L. Fodor, and R. A. Flavell. 1992. The activation of major histocompatibility complex class I genes by interferon regulatory factor-1 (IRF-1). Immunogenetics 35:378.
12. Harton, J. A., and J. P. Ting. 2000. Class II transactivator: Mastering the art of major histocompatibility complex expression. Mol. Cell. Biol. 20:6185.
13. Boss, J. M. 1997. Regulation of transcription of MHC class II genes. Curr. Opin. Immunol. 9:107.
14. Stark, G. R., I. M. Kerr, B. R. Williams, R. H. Silverman, and R. D. Schreiber. 1998. How cells respond to interferons. Annu. Rev. Biochem. 67:227.
15. Sakamoto, H., H. Yasukawa, M. Masuhara, S. Tanimura, A. Sasaki, K. Yuge, M. Ohtsubo, A. Ohtsuka, T. Fujita, T. Ohta, et al. 1998. A Janus kinase inhibitor, JAB, is an interferon-γ-inducible gene and confers resistance to interferons. Blood 92:1668.
16. Starr, R., T. A. Willson, E. M. Viney, L. J. Murray, J. R. Rayner, B. J. Jenkins, T. J. Gonda, W. S. Alexander, D. Metcalf, N. A. Nicola, and D. J. Hilton. 1997. A family of cytokine-inducible inhibitors of signalling. Nature 387:917.
17. Starr, R., D, Metcalf, A. G. Elefanty, M. Brysha. T. A. Willson. N. A. Nicola, D. J. Hilton, and W. S. Alexander. 1998. Liver degeneration and lymphoid deficiencies in mice lacking suppressor of cytokine signaling-1. Proc. Natl. Acad. Sci. USA 95:14395.
18. Alexander, W. S., R. Starr, J. E. Fenner, C. L. Scott, E. Handman, N. S. Sprigg, J. E. Corbin, A. L. Cornish, R. Darwiche, C. M. Owczarek, et al. 1999. SOCS1 is a critical inhibitor of interferon γ signaling and prevents the potentially fatal neonatal actions of this cytokine. Cell 98:597.
19. Endo, T. A., M. Masuhara, M. Yokouchi, R. Suzuki, H. Sakamoto, K. Mitsui, A. Matsumoto, S. Tanimura, M. Ohtsubo, H. Misawa, et al. 1997. A new protein containing an SH2 domain that inhibits JAK kinases. Nature 387:921.
20. Naka, T., M. Narazaki, M. Hirata, T. Matsumoto, S. Minamoto, A. Aono, N. Nishimoto, T. Kajita, T. Taga, K. Yoshizaki, et al. 1997. Structure and function of a new STAT-induced STAT inhibitor. Nature 387:924.
21. Narazaki, M., M. Fujimoto, T. Matsumoto, Y. Morita, H. Saito, T. Kajita, K. Yoshizaki, T. Naka, and T. Kishimoto. 1998. Three distinct domains of SSI-I/SOCS-I/JAB protein are required for its suppression of interleukin 6 signaling. Proc. Natl. Acad. Sci. USA 95:13130.
22. Nicholson, S. E., T. A. Willson, A. Farley, R. Starr, J. G. Zhang, M. Baca, W. S. Alexander, D. Metcalf, D. J. Hilton, and N. A. Nicola. 1999. Mutational analyses of the SOCS proteins suggest a dual domain requirement but distinct mechanisms for inhibition of LIF and IL-6 signal transduction. EMBO J. 18:375.
23. Yasukawa, H., H. Misawa, H. Sakamoto, M. Masuhara, A. Sasaki, T. Wakioka, S. Ohtsuka, T. Imaizumi, T. Matsuda, J. N. Ihle, and A. Yoshimura. 1999. The JAK-binding protein JAB inhibits Janus tyrosine kinase activity through binding in the activation loop. EMBO J. 18:1309.
24. De Sepulveda, P., K. Okkenhaug, J. L. Rose, R. G. Hawley, P. Dubreuil, and R. Rottapel. 1999. Socsl binds to multiple signalling proteins and suppresses steel factor-dependent proliferation. EMBO J. 18:904.
25. Kamura, T., S. Sato, D. Haque, L. Liu, W. G. Kaelin, R. C. Conaway, and J. W. Conaway. 1998. The Elongin BC complex interacts with the conserved SOCS-box motif present in members of the SOCS, ras, WD-40 repeat, and ankyrin repeat families. Genes Dev. 12:3872.
26. Iwai, K., K. Yamanaka, T. Kamura, N. Minato, R. C. Conaway, J. W. Conaway, R. D. Klausner, and A. Pause. 1999. Identification of the von Hippel-Lindau tumor-suppressor protein as part of an active E3 ubiquitin ligase complex. Proc. Natl. Acad. Sci. USA 96:12436.
27. Kamura, T., D. M. Koepp, M. N. Conrad, D. Skowyra, R. J. Moreland, O. Iliopoulos, W. S. Lane, W. G. Kaelin, Jr., S. J. Elledge, R. C. Conaway, et al. 1999. Rbx1, a component of the VHL tumor suppressor complex and SCF ubiquitin ligase. Science 284:657.
28. Lisztwan, J., G. Imbert, C. Wirbelauer, M. Gstaiger, and W. Krek. 1999. The von Hippel-Lindau tumor suppressor protein is a component of an E3 ubiquitin-protein ligase activity. Genes Dev. 13:1822.
29. De Sepulveda, P., S. Ilangumaran, and R. Rottapel. 2000. Suppressor of cytokine signaling-1 inhibits VAV function through protein degradation. J. Biol. Chem. 275:14005.
30. Frantsve, J., J. Schwaller, D. W. Sternberg, J. Kutok, and D. G. Gilliland. 2001. Socs-1 inhibits TEL-JAK2-mediated transformation of hematopoietic cells through inhibition of JAK2 kinase activity and induction of proteasome-mediated degradation. Mol. Cell. Biol. 21:3547.
31. Kamizono, S., T. Hanada, H. Yasukawa, S. Minoguchi, R, Kato, M. Minoguchi, K, Hattori, S. Hatakeyama, M. Yada, S. Morita, et al. 2001. The SOCS box of SOCS-1 accelerates ubiquitin-dependent proteolysis of TEL-JAK2. J. Biol. Chem. 276:12530.
32. Rottapel, R., S, Ilangumaran, C. Neale, J. La Rose, J. M. Ho, M. H. Nguyen, D. Barber, P. Dubreuil, and P. de Sepulveda. 2002. The tumor suppressor activity of SOCS-1. Oncogene 21:4351.
33. O'Keefe, G. M., V. T. Nguyen, L. L. Ping Tang, and E. N. Benveniste. 2001. IFN-γ regulation of class II transactivator promoter IV in macrophages and microglia: Involvement of the suppressors of cytokine signaling-1 protein. J. Immunol. 166:2260.
34. Song, M. M., and K. Shuai. 1998. The suppressor of cytokine signaling (SOCS) 1 and SOCS3 but not SOCS2 proteins inhibit interferon-mediated antiviral and antiproliferative activities. J. Biol. Chem. 273:35056.
35. Germain, R. N., and L. R. Hendrix. 1991. MHC class II structure, occupancy and surface expression determined by post-endoplasmic reticulum antigen binding. Nature 353:134.
36. Sangfelt, O., S. Erickson, and D. Grander. 2000. Mechanisms of interferon-induced cell cycle arrest. Front. Biosci. 5:D479.
37. Chin, Y. E., M. Kitagawa, W. C. Su, Z. H. You, Y. Iwamoto, and X. Y. Fu. 1996. Cell growth arrest and induction of cyclin-dependent kinase inhibitor p21 WAF1/CIP1 mediated by STAT1. Science 272:719.
38. 1 in mammary epithelial cells which correlates with a block in hyperphosphorylation of retinoblastoma. Cell Growth Differ. 7:289.
39. waf-1 and arrests macrophage cell cycle, preventing induction of apoptosis. Immunity 11:103.
40. Bromberg, J. F., C. M. Horvath, Z. Wen, R. D. Schreiber, and J. E. Darnell, Jr. 1996. Transcriptionally active Statl is required for the antiproliferative effects of both interferon a and interferon γ. Proc. Natl. Acad. Sci. USA 93:7673.
41. Muhlethaler-Mottet, A., W. Di Berardino, L. A. Otten, and B. Mach. 1998. Ac-γ tivation of the MHC class 11 transactivator CIITA by interferon- requires cooperative interaction between Stat1 and USF-1. Immunity 8:157.
42. Siewert, E., W. Muller-Esterl, R. Starr, P. C. Heinrich, and F. Schaper. 1999. Different protein turnover of interleukin-6-type cytokine signalling components. Eur. J. Biochem. 265:251.
43. Reith, W., A. Muhlethaler-Mottet, K. Mastemak, J. Villard, and B. Mach. 1999, The molecular basis of MHC class II deficiency and transcriptional control of MHC class II gene expression, Microbes Infect. 1:839.
44. Roche, P. A., M. S. Marks, and P. Cresswell. 1991. Formation of a nine-subunit complex by HLA class II glycoproteins and the invariant chain. Nature 354:392.
45. Cosgrove, D., D. Gray, A. Dierich, J. Kaufman, M. Lemeur, C. Benoist, and D. Mathis. 1991. Mice lacking MHC class II molecules. Cell 66:1051.
46. Sakamoto, H., I. Kinjyo, and A. Yoshimura. 2000. The Janus kinase inhibitor, Jab/SOCS-1, is an interferon-γ inducible gene and determines the sensitivity to interferons. Leuk. Lymphoma 38:49.
47. + T-cell response is mediated by repression of γ interferon-induced class II transactivator expression. J. Virol. 73:6582.
48. Zhong, G., T. Fan, and L. Liu. 1999. Chlamydia inhibits interferon γ-inducible major histocompatibility complex class II expression by degradation of upstream stimulatory factor 1. J. Exp. Med. 189:1931.
49. Zhong, G., L. Liu, T. Fan, P. Fan, and H. Ji. 2000. Degradation of transcription factor RFX5 during the inhibition of both constitutive and interferon γ-inducible major histocompatibility complex class I expression in Chlamydia-infected cells. J. Exp. Med. 191:1525.
50. Zhu, X., S. Pattenden, and R. Bremner. 1999. pRB is required for interferon-γ induction of the MHC class II αβgene. Oncogene 18:4940.
51. Borras, F. E., J. Lloberas, R. A. Maki, and A. Celada. 1995. Repression of I-Aβ gene expression by the transcription factor PU.1. J. Biol. Chem. 270:24385.
52. Choubey, D., S. J. Li, B. Datta, J. U. Gutterman, and P. Lengyel. 1996. Inhibition of E2F-mediated transcription by p202. EMBO J. 15:5668.
53. Min, W., S. Ghosh, and P. Lengyel. 1996. The interferon-inducible p202 protein as a modulator of transcription: Inhibition of NF-κB, c-Fos, and c-Jun activities. Mol. Cell. Biol. 16:359.
54. Xaus, J., M. Comalada, M. Barrachina, C. Herrero, E. Gonalons, C. Soler. J. Lloberas, and A. Celada. 2000. The expression of MHC class II genes in macrophages is cell cycle dependent. J. Immunol. 165:6364.
55. Cullell-Young, M., M. Barrachina, C. Lopez-Lopez, E. Gonalons, J. Lloberas, C. Soler, and A. Celada. 2001. From transcription to cell surface expression, the induction of MHC class II I-Aα by interferon-γ in macrophages is regulated at different levels. Immunogenetics 53:136.
56. Gonalons, E., M. Barrachina, J. A. Garcia-Sanz, and A. Celada. 1998. Translational control of MHC class II I-A molecules by IFN-γ. J. Immunol. 161:1837.
57. Raught, B., A. C. Gingras, and N. Sonenberg. 2001. The target of rapamycin (TOR) proteins. Proc. Natl. Acad. Sci. USA 98:7037.
58. Nguyen, H., C. V. Ramana, J. Bayes, and G. R. Stark. 2001. Roles of phosphatidylinositol 3′-kinase in interferon-(γ)-dependent phosphorylation of STAT1 on serine 727 and activation of gene expression. J. Biol. Chem. 3:3.
59. Van den Eynde, B. J., and S. Morel. 2001. Differential processing of class-I-restricted epitopes by the standard proteasome and the immunoproteasome. Curr. Opin. Immunol. 13:147.
60. Ramana, C. V., M. P. Gil, Y. Han, R. M. Ransohoff, R. D. Schreiber, and G. R. Stark. 2001. Stat1-independent regulation of gene expression in response to IFN-γ. Proc. Natl. Acad. Sci. USA 98:6674.
61. Hof, P., S. Pluskey, S. Dhe-Paganon, M. J. Eck, and S. E. Shoelson. 1998. Crystal structure of the tyrosine phosphatase SHP-2. Cell 92:441.
62. Sayos, J., C. Wu, M. Morra, N. Wang, X. Zhang, D. Allen, S. van Schaik, L. Notarangelo, R. Geha, M. G. Roncarolo, et al. 1998. The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM. Nature 395:462.